Stockreport

Alto Neuroscience to Participate in Upcoming Investor Conferences

Alto Neuroscience, Inc.  (ANRO) 
PDF MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel [Read more]